TrialThe New England journal of medicine2016

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Paul T Nghiem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.